Back to Search
Start Over
A harmonization effort for acceptable daily exposure derivation - Considerations for application of adjustment factors.
- Source :
-
Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2016 Aug; Vol. 79 Suppl 1, pp. S57-66. Date of Electronic Publication: 2016 May 21. - Publication Year :
- 2016
-
Abstract
- Acceptable daily exposures (ADEs) are established to determine the quantity of one drug substance that can contaminate another drug product without causing harm to the patient. An important part in setting an ADE for a drug substance, after identification of the unwanted critical effect(s) of the compound (see Bercu et al., 2016, this issue), is the determination of an appropriate overall margin of safety that is need to be maintained below the dose causing a certain critical effect (i.e., the point of departure or PoD). The overall margin of safety used to protect the general patient population from critical effects is derived as the product (i.e., composite adjustment factor) of various individual factors that account for variability and uncertainty in extrapolating from the PoD to an ADE. These factors address the considerations of interindividual variability, interspecies extrapolation, LOAEL-to-NOAEL extrapolation, exposure duration adjustment, effect severity, and database completeness. The factors are considered individually, but are not necessarily independent and their interdependence should be identified, with subsequent adjustment to the composite factor, as appropriate. It is important to identify all sources of variability and uncertainty pertinent to the derivation of the ADE and ensure each is considered in the assessment, at least by one of the adjustment factors. This manuscript highlights the basis for and selection of factors that address variability and uncertainty as used in the guidance documents on setting ADEs or other related health-based limits.<br /> (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Subjects :
- Animals
Dose-Response Relationship, Drug
Guidelines as Topic
Health Policy
Humans
Models, Biological
Occupational Exposure adverse effects
Occupational Exposure legislation & jurisprudence
Occupational Exposure standards
Policy Making
Risk Assessment
Species Specificity
Toxicity Tests
Drug Industry legislation & jurisprudence
Drug Industry standards
No-Observed-Adverse-Effect Level
Occupational Exposure prevention & control
Occupational Health legislation & jurisprudence
Occupational Health standards
Pharmaceutical Preparations classification
Pharmaceutical Preparations standards
Subjects
Details
- Language :
- English
- ISSN :
- 1096-0295
- Volume :
- 79 Suppl 1
- Database :
- MEDLINE
- Journal :
- Regulatory toxicology and pharmacology : RTP
- Publication Type :
- Academic Journal
- Accession number :
- 27221789
- Full Text :
- https://doi.org/10.1016/j.yrtph.2016.05.023